Buprenorphine is known to reduce GI motility (Imam et al., 2018), albeit to a lesser extent than full MOR agonists such as morphine (Khanna and Pillarisetti, 2015), and is a recognized contributor to opioid-induced constipation (Imam et al., 2018). This evidence concerns the gene OPRM1 and constipation disorder.